Quest Diagnostics has 1 portfolio company on record at Recent Funding. Its most recent investment on record is PreciseDx's $11M Series B+ round in June 2025, alongside Philips Health Technology Ventures, Merck Global Health Innovation Fund, LabCorp and 2 others. That company is in Health and bio. It has co-invested with LabCorp, GenHenn Venture and Eventide, most often LabCorp (2 rounds).

What Quest Diagnostics invests in

• Health and bio · 1 · 100%
• Developer tools and cloud · 1 · 100%

How Quest Diagnostics invests

Share is of the 2 rounds on Recent Funding that name Quest Diagnostics. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Quest Diagnostics portfolio companies

• PPreciseDx$11MSeries B+ · Jun 2025

Most frequent co-investors

• LLabCorp2 shared rounds · last Jun 18, 2025
• GGenHenn Venture2 shared rounds · last Jun 18, 2025
• EEventide2 shared rounds · last Jun 18, 2025
• MMerck Global Health Innovation Fund1 shared round · last Jun 18, 2025
• PPhilips Health Technology Ventures1 shared round · last Jun 18, 2025

Similar investors

• CCategory Ventures1 company · 2 deals in 12 mo
• AAmiral Ventures1 company · 1 deal in 12 mo
• BBeAble Capital1 company · 1 deal in 12 mo
• DDeviation Capital1 company · 1 deal in 12 mo
• JJIC Ventures1 company · 1 deal in 12 mo
• SShift4Good1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Quest Diagnostics, which is a subset of its real portfolio. API: /api/v1/investors/quest-diagnostics (get a free API key). More: the most active VC firms and new venture capital funds.